Breaking through the pain barrier: our latest research

COPD is more than a lung disease

Cancer gets a sting with new discovery

A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.

From bench to bedside: lessons in converting science into impact

Pauline Williams, Head of Global Health R&D, shares a unique perspective on what it takes to research new treatments and deliver them to patients around the world.

How a chance encounter led to a world-first toothpaste

Did you know that NovaMin, one of the key technologies in our toothpaste, is actually a bioactive glass most commonly used to repair bones?

TB: uniting scientists to tackle one of the world’s biggest killers

Tuberculosis – better known as TB – is one of the top ten causes of deaths worldwide. But for the first time in almost 100 years, we have taken a major step towards finding a potential new vaccine against the disease.

Inside the Open Lab

The vaccines of tomorrow

You, me and 23andMe: discovering new medicines through genetics

Explore how our new collaboration with 23andMe could help unlock the medicines of tomorrow.

Overcoming obstacles to end malaria

One of our lead physicians, Justin Green, tells us about the challenges of developing a new treatment for malaria.

The little pill that could: one medicine taking on two neglected diseases

This pill is part of the fight against not one – but two – neglected tropical diseases(NTDs) that burden some of the very poorest communities.

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

Complete the cycle – how we’re recycling inhalers

Fighting malaria in the lab and on the ground

How do consumer insights fuel our innovation?

By asking our consumers what matters to them, we can keep innovating and evolving our products.

How genomics is driving a new era of drug discovery

We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology.

How are we redefining research in HIV?

Shari Gordon works in the HIV Cure Center in North Carolina, a public-private company with one goal: discovering a cure for HIV/AIDS.

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

COPD for John just means doing everything at a slower pace

Making the Ellipta® inhaler a reality

The story behind the device now used by millions of people globally

Overcoming the challenges of COPD to fulfil a lifelong dream

Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.

Making sense of what consumers want

As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

Breaking through the pain barrier: our latest research

I control my asthma, it doesn’t control me

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear.

You'll outgrow some childhood habits, but vaccination is for life

Infectious diseases remain just as serious throughout adulthood and vaccines remain the most effective protection we have against them.

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

From TV to tackling lupus: why Alex moved from media to medicine

Giving a bit back – Christine’s experience of clinical research

Healthcare in your pocket

We are dedicated to supporting patients beyond the medicines we provide and believe that digital technology, has an important role to play in this.

The race against malaria: handing the baton to the next generation

Malaria is a preventable and treatable disease yet it still claims hundreds of thousands of lives each year, mostly in children under five.

Win for Meningitis – harnessing the power of inspirational images to create a win for disease prevention

Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.

Setting the record straight: Why we publish data both positive and negative

Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.

Making the switch: how we’re improving access to proven medicines

Supporting community health across the UK

30 years and counting: the fight against HIV

How to find a treatment for a disease with no idea what that disease actually is.

HIV research focus on finding a cure

With 34 million people around the world living with HIV/AIDS, preventing and treating HIV infection remains an enormous global challenge.

What are Bioelectronics

We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart.

Live every breath

GSK have been innovating to fight respiratory disease for over 45 years.

Vaccines: the most successful health intervention… ever

Joining forces to fight malaria

STEM inspiring real world scientists

GSK STEM Education brings real world science to life in the classroom.

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

From academia to the pharmaceutical industry – one year on

Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise.

COPD: Our relentless pursuit for better breathing

Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.

Taking action to stop pneumonia

Getting on target in autoimmune diseases

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Maternal immunisation: Helping protect mums and babies

Immunisation during pregnancy can help protect the mother, and also help protect the baby before birth and through the critical first few weeks of life.

Can social media help us hear patients?

Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.

Tackling tomorrow’s health challenges today

Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow

Don’t forget the pharmacists

Rabies – Educate, Vaccinate, Eliminate.

Partnership for Prevention

Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme.

Scientists or detectives? Seeking new clues in COPD

It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.

Collaboration: unlocking a new approach to clinical trials

The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe.

Helping to change the world

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

A new response to humanitarian crises

A partnership that is all about the chemistry

Can an iPhone transform the way we monitor and improve patient health?

We are using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

The app that could save lives

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Inhaler innovation: more than a simple piece of plastic

At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...

From microscope to telescope and beyond – exploring with NASA's CASIS

Meet Baby Mckline: a special delivery from our Save the Children partnership

Pro Mujer: supporting healthier lives in Latin America

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Turning the tide on antibiotic resistance

Guardian article: The 30-year quest for a malaria vaccine

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

The power of partnerships: transforming vaccine coverage in Mozambique

More than 35,000 children in the northern Mozambique province of Nampula are now registered with the mVacciNation pilot programme that was rolled out in 2015 by GSK and Vodafone, with funding from GAVI and USAID.

The value of vaccination

Beyond manufacturing in Chile and Madagascar

Why I #fightmalaria: Laura's story

Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Living with lupus – a patient perspective

Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.

Helping to further science and research – Howard’s perspective

TB or not TB

Bioelectronics at SXSW 2016

SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.

Delivering support for the most vulnerable communities

Healthcare charities tackle some of society’s most difficult and often overlooked challenges.

School leading the way to inspire young scientists

Dr Louise Morris wants every student at her school to have the education and opportunity to have a career in STEM.

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Telegraph article: Science hasn't answered all the questions on HIV

Igniting a revolution in scientific research and development

Guardian article: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

Guardian article: A different way of doing business to support Kenyan mothers

Find out how we are helping to cut maternal and newborn mortality rates in Kenya.

See how GSK supports STEM in the real world

Explore how we invest in the scientists of the future.

Guardian article: Finding new ways to give mothers and newborns a healthier start

Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies

Turning waste into a resource

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Comic Relief and GSK form a partnership to fight malaria

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

Intrapreneurship: keeping our fingers on the PULSE

We're encouraging our employees to explore new ideas beyond the remit of their role

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Helping to protect yourself against flu

Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.

Experimental medicine

Outgrowing asthma

TEDMED 2015: An interview with curator, Christine McNab

We interview Christine McNab, curator of The Art of Saving a Life.

STEM in the real world

At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.

TEDMED 2015: Art, inspired by vaccination

A blank canvas, Unformed clay. An empty petri dish.

Living every day with COPD: José’s story

Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him.

Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns

Less is more with advanced technologies in manufacturing

Using biology to increase quality and reduce carbon footprint

We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients

Five years. 40,000 health workers. 11 million people.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

To challenge. To change.

At GSK we’re taking on some of the world’s biggest healthcare challenges. We're on a mission to help people do more, feel better, live longer.

Health workers fighting it on the frontline

No 'silver bullet' to tackle this disease

On the frontline of Ebola prevention

Read how Robbie worked on the ground to fight Ebola.

Ebola: our fast track response

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Fluorescent bacteria - nowhere to hide

How can a new approach known as “bacteria-instructed synthesis” help to tackle bacterial infection?

Making our vaccines more accessible

Vaccines - coming in from the cold

Motivating a global coalition

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

Fighting Ebola highlights the need for more health workers

The Ebola crisis is by far the worst outbreak of the disease the world has ever seen.

The race to richer data in clinical trials

Finding new ways to use biosensors and mobile health platforms to improve patient care.

Why our transaction with Novartis is different

Ebola vaccine R&D

Forming public partnerships

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

Our humanitarian response to the Ebola outbreak

GSK's ongoing efforts to strengthen healthcare infrastructure in the most affected countries.

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

Flonase: the journey from prescription to OTC

Africa’s fight against malaria: how mothers are helping on the ground

Increasing access in India

Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population.

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Can mosquitoes prevent malaria?

Neuroscience: on the brain

The 'baby bubble'

The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Life after polio: Fatiha's story